Elder Granger - Nov 10, 2021 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role: Director
Signature: /s/ Mark Heinen, Attorney-in-Fact
Stock symbol: BTTX
Transactions as of: Nov 10, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/15/2021, 04:17 PM
Previous filing: Oct 5, 2021
Next filing: Dec 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTTX	Stock Option (Right to Buy)	Award	$0	+28.3K		$0.00	28.3K	Nov 10, 2021	Common Stock	28.3K	$10.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests as to 1/3 of the shares subject to the stock option on November 10, 2022 and the remaining shares vest in 24 equal monthly installments thereafter; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Issuer or otherwise ceases to serve as a director of the Issuer prior to any such vesting date. The stock option shall accelerate pursuant to the terms of the Non-Employee Director Compensation Policy of the Issuer. The stock option was granted on November 10, 2021.

Content

The stock option vests as to 1/3 of the shares subject to the stock option on November 10, 2022 and the remaining shares vest in 24 equal monthly installments thereafter; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Issuer or otherwise ceases to serve as a director of the Issuer prior to any such vesting date. The stock option shall accelerate pursuant to the terms of the Non-Employee Director Compensation Policy of the Issuer. The stock option was granted on November 10, 2021.